The analysis of environmental tax revenue from the chemicals and pharmaceuticals manufacturing sector in Europe for 2023 reveals significant variations among countries. France leads the sector with projected revenues, though experiencing a slight decrease, while Germany has seen growth. Poland, with a notable increase, is among the fast-growing markets, alongside Hungary. Conversely, the Czech Republic and Denmark are facing declines. Over the five-year period, Romania, Spain, and Norway demonstrate consistent average growth, suggesting robust tendencies in environmental tax implementation within the sector.
Future trends to monitor include the impact of stricter European Union policies on environmental sustainability and how transitional technologies influence tax revenues. Market conditions may vary with advancements in green chemistry and increasing focus on reducing industrial pollution. Watch for potential shifts towards more aggressive environmental taxation to drive sustainable development goals.
Top countries in Environmentally Related Tax Revenue from All Environmental Taxes in Manufacturing of Chemicals, Basic Pharmaceuticals and Preparations Share by Country (Million US Dollars PPP = 2015)
| # | 10 Countries | Percent | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 France | 39.54 | 2023 | +3.94% | -0.36% | View data |
| 2 | 2 Germany | 19.12 | 2023 | +1% | +1.68% | View data |
| 3 | 3 Poland | 9.5 | 2023 | +4.23% | +9.19% | View data |
| 4 | 4 Italy | 6.72 | 2023 | +0.95% | +0.91% | View data |
| 5 | 5 Romania | 5.11 | 2023 | +2.33% | +6.17% | View data |
| 6 | 6 Serbia | 4.59 | 2023 | +2.76% | +0.42% | View data |
| 7 | 7 Spain | 4.16 | 2023 | +4.79% | +3.67% | View data |
| 8 | 8 Czech Republic | 3.57 | 2023 | -4.31% | -4.67% | View data |
| 9 | 9 Belgium | 2.84 | 2023 | -4.05% | -1.74% | View data |
| 10 | 10 Hungary | 2.04 | 2023 | +2.55% | +9.35% | View data |
Latest reports
US Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the US pharmaceuticals market exhibited robust growth across various segments, driven by strategic investments, regulatory advancements, and...
Japan Pharmaceuticals Market Report- Q4 2024
The Japanese pharmaceutical industry in Q4 2024 exhibits dynamic shifts driven by government policies, market demand, and strategic innovations. The continuous rise of...
Germany Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presented a multifaceted landscape for the German pharmaceuticals industry, characterized by economic pressures, regulatory changes, and evolving consumer...
India Pharmaceuticals Market Report- Q4 2024
The Indian pharmaceutical industry in Q4 2024 continues to show dynamic growth, fueled by advancements in biologics and biosimilars, substantial export activities, and...
UK Pharmaceuticals Market Report- Q4 2024
The UK Pharmaceuticals market in Q4 2024 faced a dynamic landscape shaped by economic, regulatory, and competitive factors. Amidst inflationary pressures and evolving...
France Pharmaceuticals Market Report- Q4 2024
The French pharmaceuticals market in the fourth quarter of 2024 was marked by significant developments across various segments, including biopharmaceuticals, generic drugs, over-the-counter...
Canada Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the Canadian pharmaceuticals market showcased dynamic growth and adaptation across various segments. The evolving landscape was influenced...
Brazil Pharmaceuticals Market Report- Q4 2024
The Brazil pharmaceuticals market in Q4 2024 is characterized by significant trends and strategic developments across various segments. The demand for generic pharmaceuticals...
Italy Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presents a dynamic landscape for the pharmaceuticals market in Italy, characterized by significant trends and strategic developments across...
South Korea Pharmaceuticals Market Report- Q1 2025
The first quarter of 2025 has been pivotal for the pharmaceuticals industry in South Korea, marked by significant growth in the biopharmaceuticals and...